Drugs that contain Sarecycline Hydrochloride

1. List of Seysara drug patents

Can you believe SEYSARA received compensation for the extended wait time during the regulatory approval process?
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8318706 ALMIRALL Substituted tetracycline compounds
May, 2031

(8 years from now)

US9255068 ALMIRALL Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same
Feb, 2033

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9481639 ALMIRALL Substituted tetracycline compounds for treatment of inflammatory skin disorders
Aug, 2028

(5 years from now)

US8513223 ALMIRALL Substituted tetracycline compounds for treatment of inflammatory skin disorders
Dec, 2029

(6 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Oct 1, 2023

NCE-1 date: 2022-10-01

Market Authorisation Date: 01 October, 2018

Treatment: A method for treating acne in inflammatory lesions of non-nodular moderate to severe acne vulgaris patients 9 years of age and older comprising administering sarecycline hydrochloride in 60 mg, 100 mg...

Dosage: TABLET;ORAL

More Information on Dosage

SEYSARA family patents

20

United States

11

Japan

10

European Union

6

Canada

4

Spain

3

Denmark

3

Slovenia

3

Portugal

3

Poland

2

Israel

2

Turkey

2

Australia

2

Hong Kong

2

Lithuania

1

Mexico

1

Hungary

1

Croatia

1

Brazil

1

Cyprus

1

Korea, Republic of

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic